<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02915510</url>
  </required_header>
  <id_info>
    <org_study_id>GMP2016</org_study_id>
    <nct_id>NCT02915510</nct_id>
  </id_info>
  <brief_title>GMP Drink for PKU Study</brief_title>
  <official_title>Evaluating the Tolerance, Safety and Acceptability of PKU GMPro, a Whey Protein Derived Feed for the Dietary Management of Phenylketonuria in Children and Adults - a Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutricia UK Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nutricia UK Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the safety, gastrointestinal (GI) tolerance, acceptability and
      compliance of a Glycomacropeptide-based protein substitute for patients with Phenylketonuria
      (PKU).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Phenylalanine (and other amino acids)</measure>
    <time_frame>3 points throughout 28 days</time_frame>
    <description>Blood spot test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gastro-intestinal tolerance questionaire</measure>
    <time_frame>12/31 days</time_frame>
    <description>Questionaire detailing any GI symptoms, severity and change from usual</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Product compliance questionaire</measure>
    <time_frame>31 days</time_frame>
    <description>Breif questionaire on amounts offered and amounts actually consumed, compared to recomended amount.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Product acceptability questionnaire</measure>
    <time_frame>2/31 days</time_frame>
    <description>Breif tick-box questionaire on overal liking and acceptability of product</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reproted nutrient intake (3 day food diaries)</measure>
    <time_frame>6/31 days</time_frame>
    <description>3 day food diaries, subsequently analysed in dietary software.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pateint-reported appetite (visual analogue scale)</measure>
    <time_frame>6/31 days</time_frame>
    <description>Measures of overal appetite and satiety via visual analouge scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antropometry (hieight and weight)</measure>
    <time_frame>2/31 days</time_frame>
    <description>Measurements of height and weight at baseline and end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (Adverse events reporting)</measure>
    <time_frame>31 days</time_frame>
    <description>Reporting of adverse events throughout study</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Phenylketonuria</condition>
  <arm_group>
    <arm_group_label>GMP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single arm designed, 3 day baseline, 28day on GMP</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glycomacropeptide-based protein substitute</intervention_name>
    <arm_group_label>GMP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female

          -  Over 3 years of age

          -  Diagnosed with classical or variant type phenylketonuria

          -  Have been compliant in taking at least one amino acid-based, Phe-free protein
             substitute, providing at least 20g protein equivalents, for at least 1 month prior to
             trial commencement

          -  Have a prescribed daily Phe allowance

          -  Written informed consent from patient, or from parent / carer if applicable

        Exclusion Criteria:

          -  Currently prescribed Sapropterin or similar tetrahydrobiopterin based medication

          -  Pregnant or lactating

          -  Requiring parenteral nutrition

          -  Major hepatic or renal dysfunction

          -  Participation in other studies within 1 month prior to entry of this study

          -  Allergy to any of the study product ingredients, including milk protein or soya

          -  Investigator concern around willingness/ability of patient or parent/carer to comply
             with protocol requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca Stratton, PHd</last_name>
    <role>Study Director</role>
    <affiliation>Nutricia Ltd UK</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Browne, BSc</last_name>
    <email>robert.browne@nutricia.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Great Ormond Street Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rachel Skeath</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guy's and St Thomas' NHS Fondation Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Fitzachary</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCLH</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charlotte Ellerton</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Manchester Children's Hospital</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karen van Wyk</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sheffield Teaching Hospital</name>
      <address>
        <city>Sheffield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Hill</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2016</study_first_submitted>
  <study_first_submitted_qc>September 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2016</study_first_posted>
  <last_update_submitted>October 30, 2017</last_update_submitted>
  <last_update_submitted_qc>October 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylketonurias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

